Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_assertion type Assertion NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_head.
- NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_assertion description "[Using the HER-2/neu oncogenic protein as a model, a well-defined tumor antigen in breast cancer, we questioned whether patients with advanced stage HER-2/neu overexpressing breast and ovarian cancers (III/IV) had evidence of pre-existent immunity to HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_provenance.
- NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_assertion evidence source_evidence_literature NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_provenance.
- NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_assertion SIO_000772 11072789 NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_provenance.
- NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_assertion wasDerivedFrom befree-20150227 NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_provenance.
- NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_assertion wasGeneratedBy ECO_0000203 NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_provenance.